SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-321513
Filing Date
2020-12-18
Accepted
2020-12-18 16:20:28
Documents
2
Group Members
ABG MANAGEMENT LTD.ALLY BRIDGE GROUP (NY) LLCALLY BRIDGE MEDALPHA MANAGEMENT GP, LLCALLY BRIDGE MEDALPHA MANAGEMENT L.P.FAN YU

Document Format Files

Seq Description Document Type Size
1 SC 13G d75341dsc13g.htm SC 13G 119024
2 EX-99.1 d75341dex991.htm EX-99.1 8867
  Complete submission text file 0001193125-20-321513.txt   129796
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89552 | Film No.: 201400864
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 QUEENS ROAD CENTRAL, UNIT 3002-3004 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK HONG KONG F4 0000000000
Business Address 15 QUEENS ROAD CENTRAL, UNIT 3002-3004 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK HONG KONG F4 0000000000 852 31219699
Ally Bridge MedAlpha Master Fund L.P. (Filed by) CIK: 0001831963 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G